SHOX2 and breast cancer: In ER(+) breast cancer and AR(+) prostate cancer, the expression of SHOT-RNA was shown to be markedly elevated; conversely, the knockdown of SHOT-RNA expression by siRNA significantly reduced the proliferation of cancer cells (36).